MACROGENICS, INC. Current Assets
MACROGENICS, INC. (MGNX) had Current Assets of $321.69 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $321.69M.
- 2026-03-31: Assets, Current $182.52M.
- 2025-12-31: Assets, Current $219.94M.
- 2025-09-30: Assets, Current $232.09M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $321.69M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $182.52M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $219.94M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $232.09M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $204.94M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $182.09M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $217.49M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $222.20M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $156.95M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $202.57M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $251.34M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $291.32M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $254.68M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $288.94M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $222.18M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $147.81M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $167.63M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $218.20M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $279.56M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $334.70M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $367.00M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $374.72M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $312.59M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $310.07M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $260.20M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $195.28M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $239.78M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $276.23M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $287.60M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $335.03M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $269.12M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $285.64M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $322.05M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $271.04M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $322.30M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $209.47M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $250.11M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $251.01M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $283.95M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $316.29M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $348.44M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $309.27M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $342.38M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $370.50M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $242.43M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $268.47M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $164.74M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $186.96M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $198.76M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $202.40M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $119.46M 10-K · filed 2015-03-03 | $119.46M 10-K · filed 2014-03-20 |
| 2013-09-30 | $36.95M 10-Q · filed 2013-11-12 | |
| 2012-12-31 | $49.93M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |